Analysis of sentinel lymph node mapping with immediate pathologic review in patients receiving preoperative chemotherapy for breast carcinoma

被引：23

作者：

Miller A.R. ^{[1
]}

Thomason V.E. ^{[1
]}

Yeh I.T. ^{[2
]}

Alrahwan A. ^{[2
]}

Sharkey F.E. ^{[2
]}

Stauffer J. ^{[1
]}

Otto P.M. ^{[3
]}

McKay C. ^{[3
]}

Kahlenberg M.S. ^{[1
]}

Phillips W.T. ^{[3
]}

Cruz Jr. A.B. ^{[1
]}

机构：

[1] Division of Surgery, University of Texas, Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio

[2] Division of Pathology, University of Texas, Health Science Center, San Antonio, TX

[3] Division of Radiology, University of Texas, Health Science Center, San Antonio, TX

来源：

Annals of Surgical Oncology | 2002年 / 9卷 / 3期

关键词：

Axillary lymph node dissection; Breast cancer; Neoadjuvant chemotherapy; Sentinel lymph node mapping;

D O I：

10.1007/BF02573061

中图分类号：

学科分类号：

摘要：

Background: Sentinel lymph node mapping (SLNM) and neoadjuvant chemotherapy are becoming established components of therapy for selected patients with breast carcinoma. However, neoadjuvant therapy has been considered a relative contraindication to SLNM. In an effort to learn whether patients who have received preoperative chemotherapy can undergo accurate SLNM, we evaluated our experience with this technique. Methods: From January 1997 to June 2000, SLNM and axillary lymph node dissection were concurrently performed in 35 patients who received preoperative chemotherapy. Mapping was performed with 99mTc sulfur colloid only in one patient and Lymphazurin dye only in 15 patients, and the two methods were combined in the remainder. Results: SLNM successfully identified a sentinel lymph node in 30 (86%) patients. Metastatic disease was identified in the sentinel lymph nodes of four patients during surgery. The intraoperative pathologic diagnosis proved to be correct in 19 (79%) of 24 patients. The final pathologic diagnosis of the sentinel lymph node reflected the status of the axillary contents in all patients in whom it was identified. Conclusions: These results demonstrate that SLNM can be consistently performed in patients receiving preoperative chemotherapy for breast cancer, suggesting the utility of this technique in this patient population.

引用

页码：243 / 247

页数：4

共 32 条

[1]

Morton D.L., Wen D.R., Wong J.H., Et al., Technical details of intraoperative lymphatic mapping for early stage melanoma, Arch Surg, 127, pp. 392-399, (1992)

[2]

Krag D.N., Weaver D.L., Alex J.C., Fairbank J.T., Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe, Surg Oncol, 2, pp. 335-359, (1993)

[3]

Albertini J.J., Lyman G.H., Cox C., Et al., Lymphatic mapping and SLNB in the patient with breast cancer, JAMA, 276, pp. 1818-1822, (1996)

[4]

Schrenk P., Rieger R., Shamiyeh A., Wayand W., Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma, Cancer, 88, pp. 608-614, (2000)

[5]

Turner R.R., Ollila D.W., Krasne D.L., Giuliano A.E., Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma, Ann Surg, 226, pp. 271-276, (1997)

[6]

Giuliano A.E., Dale P.S., Turner R.R., Morton D.L., Evans S.W., Krasne D.L., Improved axillary staging of breast cancer with sentinel lymphadenectomy, Ann Surg, 222, pp. 394-401, (1995)

[7]

Hsueh E.C., Hansen N., Armando E.G., Intraoperative lymphatic mapping and sentinel lymph node dissection in breast carcinoma, CA Cancer J Clin, 50, pp. 279-291, (2000)

[8]

Giuliano A.E., Barth D., Spivak B., Beitsch P.D., Evans S.W., Incidence and predictors of axillary metastases in T1 carcinoma of the breast, J Am Coll Surg, 183, pp. 185-189, (1996)

[9]

Giuliano A.E., Kirgan D.M., Guenther J.M., Et al., Lymphatic mapping and sentinel lymphadenectomy for breast cancer, Ann Surg, 220, pp. 391-401, (1994)

[10]

Giuliano A.E., Jones R.C., Brennan M., Statman R., Sentinel lymphadenectomy in breast cancer, J Clin Oncol, 15, pp. 2345-2350, (1997)

← 1 2 3 4 →